This study demonstrates the need to raise awareness of the unique risks of sharps injuries in ophthalmic practice. This is necessary in order to develop speciality-specific policy that promotes strategies to reduce such injuries, enhances the accuracy of reporting of such events, and provides guidance for appropriate management.
Purpose To describe the prevalence of surgical complications in patients undergoing trabeculectomy with mitomycin C (trab + MMC). Methods A Review of an open consecutive prospective interventional case series performed by a single surgical team was undertaken. The case mix was a supra‐regional complex mixture of primary, secondary and paediatric glaucoma. Complete and qualified success rates, and the prevalence of complications were calculated. Results 382 eyes of 298 patients were included in the study. Mean follow up was 3.08 years. Mean age was 57.4 years (range: 6‐87). At latest follow up qualified success (IOP ≤ 21mmhg with ≥1 ocular hypotensive agent) was 95.7% (360 eyes) and complete success (IOP ≤ 21mmhg without an ocular hypotensive agent) was 84.8% (319 eyes). Early postoperative complications ≤1 month of surgery were reported in 21 (5.5%) eyes. 7 (1.8%) eyes developed late surgery related complications >1 month of surgery. Clinically significant early hypotony (IOP <6 on 2 separate occasions and requiring surgical intervention) occurred in 17 (4.5%) eyes. 2 patients developed late hypotony including 1 case of hypotony maculopathy, and there was 1 case each of toxic anterior segment syndrome, corneal decompensation plus cystoid macular oedema (ICE syndrome patient), blebitis, endophthalmitis, aqueous misdirection, suprachoroidal haemorrhage, retinal tear, and epiretinal membrane. No patients developed choroidal neovascularisation or malignant glaucoma. 1 patient developed pulmonary oedema after general anaesthesia. Conclusion Trab + MMC in a complex supra‐regional case mix service is a highly effective and safe operation. Only 3 (0.8%) eyes developed irreversible vision loss > 2 lines Snellen.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.